格林在神经保护和认知功能中的潜在作用:对糖尿病认知障碍的影响
Yuhan Zhang1, Ruihua Zhang1, Xin Wang1
1Department of Pharmacology, Shaanxi University of Chinese Medicine, Xi'an, Xianyang, China.
PeerJ
|February 25, 2025
概括
格林林可以帮助治疗糖尿病认知障碍 (DCI). 调节格林水平改善了大鼠的认知功能,这表明DCI和阿尔茨海默病的治疗潜力.
科学领域:
- 神经内分泌学神经内分泌学
- 代谢障碍 代谢障碍 代谢障碍
- 神经退行性疾病研究
背景情况:
- 格雷林是一种类激素,调节食欲,葡萄糖和平衡.
- 格林素影响中枢神经系统的功能,包括学习和记忆.
- 糖尿病认知障碍 (DCI) 是糖尿病的并发症,与阿尔茨海默病和改变的 ghrelin 水平有关.
研究的目的:
- 审查DCI的病变发生过程.
- 探索格林在调节DCI中的潜在作用.
- 阐明格林对DCI的治疗前景.
主要方法:
- 关于DCI病变的综合文献综述.
- 对格林对认知功能的影响研究的分析.
- 对格林模仿剂对DCI的治疗潜力的审查.
主要成果:
- 糖尿病和认知障碍患者的格林林水平发生变化.
- 格林林调节在DCI大鼠模型中改善了认知功能.
- 格雷林及其模仿剂在DCI中显示出潜在的治疗重要性.
结论:
- 格林在DCI的发病过程中起着重要作用.
- 格雷林及其模仿物代表了DCI的有希望的治疗点.
- 对基于ghrelin的治疗方法的进一步研究可以促进DCI的预防和管理.
相关概念视频
Hypoglycemia and Glucagon
149
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
149
Role of Neurotransmitters in Memory
384
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
384
Glucagon-like Receptor Agonists
291
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
291
Psychoneuroimmunology: Diabetes and Cancer
21
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
21
Regulation of Food Intake
176
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
176
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
95
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
95


